Surya Singh

Surya Singh, MD, currently serves as the CEO of InformedDNA since May 2023 and is a Senior Advisor at the Institute for Clinical and Economic Review. Additionally, Surya Singh is the President and founder of Singh Healthcare Advisors, providing consultancy in various healthcare sectors. As a co-founder and CEO of gWell from September 2019 to September 2023, Surya Singh has contributed significantly to healthcare innovation. Previous roles include Attending Physician at Brigham and Women's/Faulkner Hospitals and Corporate Vice President & Chief Medical Officer, Specialty at CVS Health, where leadership encompassed strategic growth and multidisciplinary team management. Surya Singh also held Chief Medical Officer positions at Proventys and D2Hawkeye, and served as an Engagement Manager at McKinsey and Company. Surya Singh earned a Doctor of Medicine degree from The Johns Hopkins University School of Medicine and a Bachelor of Science in Molecular Biology from The University of Texas at Austin.